The study, compiled by IQVIA, covers 160 drugs, including 41 oncology drugs and 57 orphan drugs whic...
Read moreThe amendment includes a number of articles which aims to “streamline the negotiation of the price...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreBeyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...
Read moreAccording to the pharmaceutical industry association, Farmaindustria, 40% of orphan drugs approved i...
Read moreThe Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...
Read more14 new orphan drugs were made available in the national health service (Sistema Nacional de Salud, S...
Read moreThe Court has annulled the inclusion of the orphan drug Onivyde (irinotecan) in the reference price ...
Read moreAccording to the Institute for Quality and Efficiency in Health Care orphan drugs should undergo ear...
Read moreAccording to the Institute for Quality and Efficiency in Health Care orphan drugs should undergo a r...
Read more